Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: 2cureX AB

Market Cap 7.43M 761K 670K 618K 578K 1.08M 71.75M 1.1M 2.88M 35.39M 2.86M 2.8M 123M P/E 2022
-4.81x
P/E 2023 -1.09x
Enterprise Value -5.97M -612K -539K -497K -465K -871K -57.71M -887K -2.31M -28.47M -2.3M -2.25M -99.04M EV / Sales 2022
29.3x
EV / Sales 2023 7.46x
Free-Float
34.89%
Yield 2022 *
-
Yield 2023 -
1 day+0.11%
1 week-6.37%
Current month+1.29%
1 month+1.51%
3 months+72.66%
6 months+147.63%
Current year+266.15%
1 week 1.7
Extreme 1.702
2.4
1 month 1.64
Extreme 1.64
2.4
Current year 0.52
Extreme 0.52
3.27
1 year 0.51
Extreme 0.514
4.4
3 years 0.2
Extreme 0.203
5.52
5 years 0.2
Extreme 0.203
19.4
10 years 0.2
Extreme 0.203
31.5
Manager TitleAgeSince
Chief Operating Officer 67 01/01/2006
Chief Executive Officer 73 -
Chief Executive Officer 50 29/12/2023
Director TitleAgeSince
Chairman 73 16/12/2024
Director/Board Member 67 01/01/2006
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%-6.37%-47.13%-57.99% 6.17M
+5.40%+11.78%+113.28%+123.77% 4.29B
+11.58%+15.55%+82.07%+188.11% 2.76B
-1.06%+4.80%-25.45%-40.36% 2.04B
-1.58%+10.69%+131.38%-42.23% 1.98B
+5.12%+12.61%+40.04%+214.76% 1.3B
-0.37%-5.44%-18.83%+26.53% 814M
+6.24%+9.77%+156.95%-55.27% 792M
-3.08%-8.24%-33.57%-19.29% 500M
+8.77%-25.97%+34.60% - 474M
Average +3.13%+2.14%+43.33%+37.56% 1.5B
Weighted average by Cap. +4.29%+4.19%+72.33%+78.09%

Financials

2022 2023
Net sales 3.37M 345K 304K 280K 262K 491K 32.54M 500K 1.3M 16.05M 1.3M 1.27M 55.85M 2.95M 302K 266K 245K 229K 430K 28.46M 438K 1.14M 14.04M 1.13M 1.11M 48.85M
Net income -29.77M -3.05M -2.69M -2.48M -2.32M -4.34M -288M -4.42M -11.53M -142M -11.45M -11.2M -493M -32.52M -3.33M -2.93M -2.71M -2.53M -4.74M -314M -4.83M -12.6M -155M -12.51M -12.24M -539M
Net Debt -44.89M -4.6M -4.05M -3.74M -3.49M -6.55M -434M -6.67M -17.39M -214M -17.27M -16.9M -744M -13.4M -1.37M -1.21M -1.12M -1.04M -1.95M -129M -1.99M -5.19M -63.86M -5.16M -5.04M -222M
Logo 2cureX AB
2cureX AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of diagnostic substances to select treatment for cancer patients. The Company's product candidate, IndiTreat - CRC, aims at optimizing medical treatment for the colorectal cancer patients. Through IndiTreat - CRC, healthcare professionals collect a tumor sample from patients to create a number of three-dimensional micro tumors in order to test available chemotherapies and experimental treatments. The Company's product pipeline includes also IndiTreat - OVA, targeting ovarian cancer treatment, and IndiTreat - KDN, focusing on kidney cancer treatment. It operates through 2cureX A/S.
Employees
14
Date Price Change Volume
24/06/26 SEK 1.882 +0.11% 28,169
23/06/26 SEK 1.880 -5.81% 23,945
22/06/26 SEK 1.996 +4.50% 81,750
18/06/26 SEK 1.910 -4.98% 35,531
17/06/26 SEK 2.010 +22.56% 222,072
  1. Stock Market
  2. Stocks
  3. 2CUREX Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!